comparemela.com
Home
Live Updates
Low Dose Therapeutic Strategy - Breaking News
Pages:
Latest Breaking News On - Low dose therapeutic strategy - Page 1 : comparemela.com
Actinium Pharmaceuticals, Inc Announces Participation in Two Panel Discussions at the 3rd Targeted Radiopharmaceuticals Summit
/PRNewswire/ Actinium Pharmaceuticals, Inc. (NYSE AMERICAN: ATNM) ("Actinium" or the "Company"), a leader in the development of targeted radiotherapies for.
Hans vitzthum
Mary chen
Helen kotanides
Preclinical development
Lifesci advisors
Exchange commission
Months of development alpha emitting therapies
Astellas pharma inc
Actinium pharmaceuticals inc
Translational research
Clinical development
Memorial sloan kettering cancer center
Actinium pharmaceuticals
Targeted radiopharmaceuticals summit
Targeted radiopharmaceuticals
Alpha emitting therapies
vimarsana © 2020. All Rights Reserved.